Literature DB >> 8443953

The short bowel syndrome: what's new and old?

J M Nightingale1, J E Lennard-Jones.   

Abstract

Conditions which resulted in colonic preservation such as strangulated hernia, intestinal volvulus, and mesenteric infarction were once the main reasons for a major intestinal resection leading to the short bowel syndrome. Now Crohn's disease is the most common underlying diagnosis; such patients often have a jejunostomy. A measurement of the residual jejunal length from the duodenojejunal flexure makes possible predictions of patient outcome. Patients with a jejunostomy and less than 100 cm jejunum usually need long-term parenteral support, whereas 50 cm or more of jejunum usually suffices for adequate oral nutrition if the colon is preserved. While patients with and without a colon have problems with nutrient absorption, those with a jejunostomy also have problems of water, sodium and magnesium losses. Stomal losses may exceed oral intake and all such patients ('secretors') need parenteral supplements. Fluid and sodium losses can be reduced by octreotide, omeprazole or H2 blockers but not sufficiently to avoid the need for intravenous supplements. Colonic preservation increases the incidence of calcium oxalate renal stones (20%). Patients with and without a colon have a high prevalence of gallstones (40%). Clinically important intestinal adaptation occurs in those with a colon but not in those with a jejunostomy. Many surgical techniques, including small bowel transplantation, have been suggested to improve absorption, but as the quality of life of most patients with a short bowel is good with current treatments, they are not at present recommended.

Entities:  

Mesh:

Year:  1993        PMID: 8443953     DOI: 10.1159/000171397

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  11 in total

Review 1.  The use of hormonal growth factors in the treatment of patients with short-bowel syndrome.

Authors:  Palle B Jeppesen
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Enhancing bowel adaptation in short bowel syndrome.

Authors:  Palle Bekker Jeppesen; Per Brobech Mortensen
Journal:  Curr Gastroenterol Rep       Date:  2002-08

3.  Accuracy and inter-operator variability of small bowel length measurement at laparoscopy.

Authors:  Benny Gazer; Danny Rosin; Barak Bar-Zakai; Udi Willenz; Ofer Doron; Mordechai Gutman; Avinoam Nevler
Journal:  Surg Endosc       Date:  2017-04-13       Impact factor: 4.584

4.  Postoperative enteroenteric intussusception in patients with Crohn's disease: report of two cases.

Authors:  Motoi Uchino; Hiroki Ikeuchi; Hiroki Matsuoka; Keita Tanaka; Takashi Kuno; Tsutomu Ohshima; Kiyoshi Tsukamoto; Mitsuhiro Nakamura; Makoto Gega; Toshihiko Yagyu; Hiroki Nakano; Masafumi Noda; Naohiro Tomita
Journal:  Surg Today       Date:  2008-03-27       Impact factor: 2.549

Review 5.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

6.  Correlation Between the Total Small Bowel Length and Anthropometric Measures in Living Humans: Cross-Sectional Study.

Authors:  Mohamed Bekheit; Mohamed Y Ibrahim; Wael Tobar; Ibrahim Galal; Athar S Elward
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

7.  Risk factors for short bowel syndrome in patients with Crohn's disease.

Authors:  Motoi Uchino; Hiroki Ikeuchi; Toshihiro Bando; Hiroki Matsuoka; Yoshiko Takahashi; Yoshio Takesue; Takayuki Matsumoto; Naohiro Tomita
Journal:  Surg Today       Date:  2011-12-17       Impact factor: 2.549

8.  A multicellular approach forms a significant amount of tissue-engineered small intestine in the mouse.

Authors:  Frédéric G Sala; Jamil A Matthews; Allison L Speer; Yasuhiro Torashima; Erik R Barthel; Tracy C Grikscheit
Journal:  Tissue Eng Part A       Date:  2011-05-04       Impact factor: 3.845

9.  Fgf9 signaling regulates small intestinal elongation and mesenchymal development.

Authors:  Michael J Geske; Xiuqin Zhang; Khushbu K Patel; David M Ornitz; Thaddeus S Stappenbeck
Journal:  Development       Date:  2008-07-24       Impact factor: 6.868

10.  Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome.

Authors:  Palle Bekker Jeppesen
Journal:  Therap Adv Gastroenterol       Date:  2012-05       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.